Stem Point Capital LP Zai Lab LTD Transaction History
Stem Point Capital LP
- $312 Billion
- Q2 2025
A detailed history of Stem Point Capital LP transactions in Zai Lab LTD stock. As of the latest transaction made, Stem Point Capital LP holds 250,438 shares of ZLAB stock, worth $5.51 Million. This represents 2.81% of its overall portfolio holdings.
Number of Shares
250,438
Previous 26,421
847.87%
Holding current value
$5.51 Million
Previous $955 Million
817.19%
% of portfolio
2.81%
Previous 0.3%
Shares
2 transactions
Others Institutions Holding ZLAB
# of Institutions
166Shares Held
37.7MCall Options Held
150KPut Options Held
201K-
Capital World Investors Los Angeles, CA6.04MShares$133 Million0.03% of portfolio
-
Rtw Investments, LP New York, NY5.54MShares$122 Million2.97% of portfolio
-
Clearbridge Investments, LLC New York, NY4.01MShares$88.3 Million0.12% of portfolio
-
Janus Henderson Group PLC London, X02.2MShares$48.4 Million0.04% of portfolio
-
Bamco Inc New York, NY1.59MShares$34.9 Million0.16% of portfolio
About Zai Lab Ltd
- Ticker ZLAB
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 97,908,704
- Market Cap $2.15B
- Description
- Zai Lab Limited develops and commercializes therapies to treat oncology, autoimmune disorders, infectious diseases, and neuroscience primarily in Mainland China and Hong Kong. The company's commercial products include Zejula, a once-daily small-molecule poly polymerase 1/2 inhibitor; Optune, a device that delivers tumor treating fields; NUZYRA f...